NEVVI Medicare utilization intelligence

← back

LA PORTE, PAULM.D., PH.D. NPI 1962760074 Clinician

Hematology-Oncology · CERRITOS, CA

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 14 years since medical school (class of 2012, self-reported to CMS)
Location CERRITOS, CA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 37 codes billed · 12,975 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
CEDARS-SINAI MEDICAL CARE FOUNDATION
2021–2026
THE ONCOLOGY INSTITUTE CA, A PROFESSIONAL CORPORATION
2019–2026
CEDARS-SINAI MEDICAL CARE FOUNDATION
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2021-02

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
J0640 Injection, leucovorin calcium, per 50 mg
J9190 Injection, fluorouracil, 500 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
96413 Administration of chemotherapy into vein, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
36415 Insertion of needle into vein for collection of blood sample
96372 Injection of drug or substance under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
82378 Carcinoembryonic antigen (cea) protein level
83615 Lactate dehydrogenase (enzyme) level
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
J1200 Injection, diphenhydramine hcl, up to 50 mg
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
84550 Uric acid level, blood
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
84100 Phosphate level
82977 Glutamyltransferase (liver enzyme) level
96361 Infusion into a vein for hydration, each additional hour
96523 Irrigation of implanted venous access drug delivery device
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
J7030 Infusion, normal saline solution , 1000 cc
82248 Bilirubin level, direct
96127 Assessment of emotional or behavioral problems
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.